Inpharma Weekly

, Volume 1632, Issue 1, pp 26–26 | Cite as

EU Commission refers lapatinib back to CHMP.

Media release


Breast Cancer Marketing Medium Release Lapatinib Oral Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations